Pancreatic Cancer Research

ResearcherNational Institute of Genomic MedicineActive in the last 2 years

Vilma Maldonado

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7254-5961; OpenAlex author ID A5019748555. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Pancreatic Cancer Stem Cells Co-Expressing SOX2, OCT4, and TERT high Represent an Aggressive Subpopulation. Co-author DOI 10.3390/cells15020129↗
  2. Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/ijms262210898↗
  3. Tumor Microenvironment Role in Pancreatic Cancer Stem Cells. First author DOI 10.3390/cells12121560↗
  4. Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets. Last author DOI 10.3390/ijms231911438↗
  5. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ijms22126374↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jorge Meléndez-Zajgla · 5 shared papers, 2021–2026 · strength 1.40
  2. Erika Curiel-Gomez · 1 shared paper, 2026 · strength 0.39
  3. Jonathan González-Ruíz · 1 shared paper, 2025 · strength 0.27
  4. Aaron Galindo-Vega · 1 shared paper, 2023 · strength 0.26
  5. Ismael Domínguez-Rosado · 1 shared paper, 2022 · strength 0.20
  6. Jorge Yassen Díaz-Blancas · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.